Identification, Characterization, and Suppression of Side Products Formed during the Synthesis of [177Lu]Lu-PSMA-617
- PMID: 33826320
- DOI: 10.1021/acs.jmedchem.1c00045
Identification, Characterization, and Suppression of Side Products Formed during the Synthesis of [177Lu]Lu-PSMA-617
Abstract
In recent years, radiolabeled tracers targeting prostate-specific membrane antigen (PSMA) have had a tremendous impact on prostate cancer management. Here, we report on the formation of radioactive impurities formed during the clinical production of 177Lu-labeled PSMA-617. We provide compelling evidence that these impurities are the result of a spontaneous, thermally mediated condensation reaction of the Glu-CO-Lys moiety resulting in the formation of three different five-membered ring systems. Density functional theory (DFT) calculations show that the condensation and cyclization of the Glu-CO-Lys moiety is thermodynamically spontaneous. In cell experiments, no affinity of these cyclized compounds toward PSMA was observed. HPLC analyses of urine samples from patient studies showed rapid renal excretion of these radioactive cyclized species. Radiolabeling conditions were identified that significantly reduced the formation of cyclized side products yielding 177Lu-labeled PSMA-617 in high radiochemical yield and purity in concordance with current good manufacturing practice (cGMP) requirements.
Similar articles
-
Automated radiosynthesis of [68 Ga]Ga-PSMA-11 and [177 Lu]Lu-PSMA-617 on the iPHASE MultiSyn module for clinical applications.J Labelled Comp Radiopharm. 2021 Mar;64(3):140-146. doi: 10.1002/jlcr.3889. Epub 2020 Nov 2. J Labelled Comp Radiopharm. 2021. PMID: 33067810 Free PMC article.
-
Enhancing Treatment Efficacy of 177Lu-PSMA-617 with the Conjugation of an Albumin-Binding Motif: Preclinical Dosimetry and Endoradiotherapy Studies.Mol Pharm. 2018 Nov 5;15(11):5183-5191. doi: 10.1021/acs.molpharmaceut.8b00720. Epub 2018 Oct 5. Mol Pharm. 2018. PMID: 30251544
-
Improvement of End-of-Synthesis Radiochemical Purity of 177Lu-DOTA-PSMA-Ligands with Alternative Synthesis Approaches: Conversion Upswing and Side-Products Minimization.Pharmaceutics. 2024 Nov 30;16(12):1535. doi: 10.3390/pharmaceutics16121535. Pharmaceutics. 2024. PMID: 39771514 Free PMC article.
-
A Walk with Lu-177 PSMA: How Close we Have Reached from Bench to Bedside?Cancer Invest. 2020 Sep;38(8-9):486-492. doi: 10.1080/07357907.2020.1811301. Epub 2020 Sep 14. Cancer Invest. 2020. PMID: 32804008 Review.
-
[177Lu-PSMA therapy : Current evidence for use in the treatment of patients with metastatic prostate cancer].Urologe A. 2017 Nov;56(11):1440-1444. doi: 10.1007/s00120-017-0510-5. Urologe A. 2017. PMID: 28986618 Review. German.
Cited by
-
Byproducts in the synthesis of [68Ga]Ga-PSMA-11.Nat Protoc. 2025 Apr 18. doi: 10.1038/s41596-025-01164-6. Online ahead of print. Nat Protoc. 2025. PMID: 40251421 No abstract available.
-
Radiolysis-Associated Decrease in Radiochemical Purity of 177Lu-Radiopharmaceuticals and Comparison of the Effectiveness of Selected Quenchers against This Process.Molecules. 2023 Feb 16;28(4):1884. doi: 10.3390/molecules28041884. Molecules. 2023. PMID: 36838872 Free PMC article.
-
Synthesis, 123I-Radiolabeling Optimization, and Initial Preclinical Evaluation of Novel Urea-Based PSMA Inhibitors with a Tributylstannyl Prosthetic Group in Their Structures.Int J Mol Sci. 2023 Jul 30;24(15):12206. doi: 10.3390/ijms241512206. Int J Mol Sci. 2023. PMID: 37569582 Free PMC article.
-
Lutetium-177-Labeled Prostate-Specific Membrane Antigen-617 for Molecular Imaging and Targeted Radioligand Therapy of Prostate Cancer.Adv Pharm Bull. 2023 Nov;13(4):701-711. doi: 10.34172/apb.2023.079. Epub 2023 Apr 29. Adv Pharm Bull. 2023. PMID: 38022814 Free PMC article. Review.
-
Automated radiosynthesis and preclinical evaluation of two new PSMA-617 derivatives radiolabelled via [18F]AlF2+ method.EJNMMI Radiopharm Chem. 2024 Jun 21;9(1):50. doi: 10.1186/s41181-024-00280-0. EJNMMI Radiopharm Chem. 2024. PMID: 38904859 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous